Cholestech (CTEC) Partners with Onsite Health Diagnostics for On-site, Corporate Health Screenings
More News related to CTEC
- China Agritech Receives Approval for NASDAQ Listing; New Symbol "CAGC"
- Cholestech (CTEC) Receives FDA CLIA Waived Status for New Combined Test Panel
- Stifel Nicolaus Upgrades Inverness Medical Innovations (IMA) to Buy
- StreetInsider.com Unusual 11 Mid-Day Movers 06/04/2007
- Inverness Medical Innovations (IMA) to Acquire Cholestech (CTEC)
More News related to Corporate News
- Shares of Brocade (BRCD) Outperforming as Oscar Gruss Upgrades to Buy
- Kinross (KGC) Jumps Higher as Gold Breaks $1,200, JPMorgan Upgrades to Overweight
- Raymond James Upgrades PSS World Medical (PSSI) to Outperform
- Capital One Southcoast Upgrades Penn Virginia (PVA) to Add; Turning Bullish After Data Release
- Raymond James Upgrades CPFL Energia S.A. (CPL) to Outperform
Cholestech Corporation (Nasdaq: CTEC) has teamed up with Onsite Health Diagnostics, one of the largest providers of comprehensive, on-site, corporate health screenings. The agreement, valued at an estimated $3 million dollars over the next three years, establishes Cholestech LDX testing system as the preferred device for Onsite screeners to monitor for risk factors associated with stroke, heart disease, diabetes and inflammatory disorders.
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
